<?xml version="1.0" encoding="UTF-8"?>
<p>Post-mortem necropsy did not find obvious gross lesions in all organs immunized with Bartha-gCD
 <sub>
  <italic>HB</italic>
 </sub>
 <sub>1201</sub> (
 <xref ref-type="fig" rid="F6">Figure 6</xref> and 
 <xref ref-type="supplementary-material" rid="TS5">Supplementary Table S5</xref>). Consistently, the HE staining revealed significantly reduced microscopic lesions in all tissues examined (
 <xref ref-type="fig" rid="F7">Figure 7</xref>). For the viral tissue load (
 <xref ref-type="fig" rid="F8">Figure 8B</xref>), Bartha-gCD
 <sub>
  <italic>HB</italic>
 </sub>
 <sub>1201</sub> significantly reduced the viral load in brain, in addition to other tissues, a stark difference from that for the groups Bartha-gC
 <sub>
  <italic>HB</italic>
 </sub>
 <sub>1201</sub> and Bartha-gD
 <sub>
  <italic>HB</italic>
 </sub>
 <sub>1201</sub>. Immunohistochemical staining of viral antigens showed the similar trend (
 <xref ref-type="fig" rid="F9">Figure 9</xref>). Thus, gC and gD display apparently a synergistic effect on induction of protective immunity against lethal challenge of epidemic strain HB1201.
</p>
